🇺🇸 FDA
Patent

US 12109229

Treatment of neurodegenerative disease with sodium chlorite

granted A61KA61K33/20A61K45/06

Quick answer

US patent 12109229 (Treatment of neurodegenerative disease with sodium chlorite) held by The Regents of the University of California expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K33/20, A61K45/06, A61P, A61P25/28